Company Filing History:
10 out of 5,307 
1 out of 832,761 Years Active: 1991-2010
Title: Innovations of Alan M. Krensky: Pioneering Antimicrobial and Immunomodulating Peptides
Introduction
Alan M. Krensky is an esteemed inventor based in Stanford, California, with a remarkable record of 11 patents. His innovative work primarily focuses on the development of antimicrobial peptides and immunomodulating compounds, which have significant implications for medical science.
Latest Patents
Among Krensky's notable recent patents are advancements in antimicrobial peptides and immunomodulating dimers. His patented antimicrobial peptides involve modifications of alpha helical portions of the protein granulysin to enhance their antimicrobial efficiency while ensuring they do not harm mammalian cells, thus preventing potential toxicity to the host. This smart adaptability enables the design of peptides according to strict guidelines, with various modifications allowed to optimize their structure and efficacy.
Additionally, his work on immunomodulating dimers includes peptide-like compounds with enhanced immunomodulating activity, featuring variants that are N-terminal acylated and/or C-terminal amidated or esterified, and containing up to 60 amino acids. These inventions follow a specific formula that emphasizes their potential in therapeutic applications.
Career Highlights
Krensky has made significant contributions through his roles in reputable institutions, including the Leland Stanford Junior University. His work at such esteemed organizations reflects his commitment to advancing scientific knowledge and clinical applications in the field of medicine.
Collaborations
Throughout his career, Krensky has collaborated with distinguished colleagues such as Carol A. Clayberger and Steffen Stenger. These partnerships illustrate the collaborative nature of innovation and the value of collective expertise in achieving scientific breakthroughs.
Conclusion
Alan M. Krensky's contributions to the field of antimicrobial and immunomodulating peptides highlight his innovative spirit and dedication to improving health outcomes. His patents, grounded in scientific rigor and creativity, pave the way for potential development in medical therapies and set a benchmark for future innovations in the pharmaceutical industry.